v3.20.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash $ 2,677,661 $ 25,063
Accounts receivable 1,742,001 2,075,380
Factor receivables, net 981,278 174,042
Inventory 1,833,100 2,215,497
Prepaid assets 199,586 254,070
Note receivable 4,480,000 4,480,000
Total Current Assets 11,913,626 9,224,052
Other Assets    
Property and equipment, net 1,103,823 1,029,885
Other assets 220,688 215,688
Total Assets 13,238,137 10,469,625
Current Liabilities    
Accounts payable 1,788,740 2,536,871
Accrued expenses 460,227 364,309
Factor loan payable 723,805 125,645
Convertible notes payable, net of discount 4,634,606 4,216,307
Total Current Liabilities 7,607,378 7,243,132
Total Liabilities 7,607,378 7,243,132
Shareholders' Equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 10,979,768 and 3,300,015 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 1,099 330
Additional paid-in capital 49,826,064 41,823,048
Accumulated deficit (47,168,029) (43,413,370)
Total Shareholders' Equity (Deficit) 5,630,759 3,226,493
Total Liabilities and Shareholders' Equity 13,238,137 10,469,625
Series D Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock value 2,971,625 4,816,485
Total Shareholders' Equity (Deficit) 2,971,625 4,816,485
Series C Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock value
Total Shareholders' Equity (Deficit)

Source